Healthy potentially undervalued

Results

2521

Companies which are potentially undervalued and in an acceptable financial position.

2521 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	EGLA	€1.00	8.4%	-55.8%	€162.7m	€1.23	0.2	100.8%	4.2%	Capital Goods
	DEME	€168.00	-2.0%	30.8%	€4.2b	€221.75	12.2	4.7%	2.7%	Capital Goods
	ADUS	US$106.32	4.0%	-7.1%	US$1.9b	US$133.00	19.5	11.1%	n/a	Healthcare
	TESB	€19.80	-4.6%	-24.1%	€1.2b	€25.50	0.4	74.6%	3.8%	Materials
	FGR	€119.05	-5.6%	0.08%	€11.3b	€161.21	11.1	7.3%	4.0%	Capital Goods
	FLOC	US$20.29	-1.8%	12.6%	US$1.7b	US$31.56	19.9	37.9%	1.8%	Energy
	CABKA	€2.02	-1.0%	4.9%	€49.9m	€3.28	0.3	105.5%	0%	Materials
	SAM	US$178.28	0.4%	-8.1%	US$1.9b	US$228.01	0.9	38.4%	n/a	Food, Beverage & Tobacco
	IMG	CA$21.29	-5.4%	124.6%	CA$13.0b	CA$35.91	8.6	5.8%	n/a	Materials
	TRLV	US$8.89	-6.8%	98.4%	US$1.7b	US$19.56	1.5	128.8%	n/a	Pharmaceuticals & Biotech
	SSRM	CA$39.89	-0.5%	135.3%	CA$8.8b	CA$61.08	10.4	10.0%	0%	Materials
	ICG	UK£17.31	1.1%	-12.0%	UK£4.8b	UK£24.42	10.0	10.4%	5.0%	Diversified Financials
	CEVI	SEK 132.00	-3.6%	-28.1%	SEK 3.1b	SEK 168.75	23.5	16.8%	2.1%	Healthcare
	XP	US$15.44	-4.6%	-19.5%	US$8.2b	US$23.65	7.8	10.7%	1.3%	Diversified Financials
	LKNC.Y	US$33.54	15.5%	-15.5%	US$10.2b	US$45.77	20.6	22.2%	n/a	Consumer Services
	HITI	CA$3.14	-2.8%	-2.2%	CA$275.9m	CA$7.30	0.4	172.6%	n/a	Pharmaceuticals & Biotech
	ATMU	US$49.52	-0.2%	28.0%	US$4.2b	US$66.40	19.2	10.9%	0.4%	Capital Goods
	PLOW	US$43.22	-17.3%	39.6%	US$1.0b	US$55.25	19.2	15.0%	2.7%	Capital Goods
	FRP	UK£1.13	-1.3%	-8.9%	UK£273.0m	UK£2.05	11.9	13.6%	4.8%	Diversified Financials
	EN	€46.16	-3.0%	17.3%	€17.8b	€59.03	14.8	9.9%	4.5%	Capital Goods
	URBN	US$68.02	-3.6%	-5.4%	US$5.8b	US$84.85	12.3	4.8%	n/a	Retail
	INR	US$13.14	6.7%	-11.4%	US$807.5m	US$23.00	5.7	51.7%	n/a	Energy
	SPRY	US$8.10	2.0%	-54.7%	US$813.3m	US$29.25	8.1	62.4%	n/a	Pharmaceuticals & Biotech
	EMBLA	DKK 26.45	-1.3%	-18.6%	DKK 11.3b	DKK 32.90	20.1	12.6%	0%	Healthcare

Page 1 of 71